Cytokines and pathological sleep

Sleep Medicine

Volumn 9, Issue 6, 2008, Pages 603-614

  Kapsimalis, Fotis ^a   Basta, Maria ^b   Varouchakis, George ^a   Gourgoulianis, Konstantinos ^c   Vgontzas, Alexandros ^b   Kryger, Meir ^d  

^a HENRY DUNANT HOSPITAL   (Greece)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF THESSALY   (Greece)

^d Gaylord Hospital Wallingford   (United States)

Author keywords

Cytokines; Excessive daytime sleepiness; Inflammation; Insomnia; Insulin resistance; Narcolepsy; Sleep apnea; Sleep deprivation

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CORTICOTROPIN; CYTOKINE; ETANERCEPT; GHRELIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HLA ANTIGEN CLASS 2; HLA DR2 ANTIGEN; HYDROCORTISONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; LEPTIN; NEURONAL NITRIC OXIDE SYNTHASE; RESISTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VASCULOTROPIN;

ANOREXIA; CANCER IMMUNOTHERAPY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DAYTIME SOMNOLENCE; DEPRESSION; DRUG EFFICACY; DRUG INDUCED HEADACHE; HEAD AND NECK SURGERY; HUMAN; INSOMNIA; MYALGIA; NARCOLEPSY; NEOPLASM; NEUROENDOCRINE SYSTEM; NONHUMAN; OBESITY; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP WAKING CYCLE; SOMNOLENCE; THERAPY EFFECT;

CARDIOVASCULAR DISEASES; CYTOKINES; DISORDERS OF EXCESSIVE SOMNOLENCE; HUMANS; OBESITY; RISK FACTORS;

EID: 48449086888     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2007.08.019     Document Type: Review

References (126)

1. Kapsimalis F., Richardson G., Opp M., and Kryger M. Cytokines and normal sleep. Curr Opin Pulm Med 11 6 (2005) 481-484
2. Blalock J.E. A molecular basis for bidirectional communication between the immune and neuroendocrine system. Physiol Rev 69 (1989) 1-32
3. Moldofsky H. Central nervous system and peripheral immune functions and the sleep-wake system. J Psychiatr Neurosci 19 5 (1994) 368-374
4. Dinarello C.A. The biology of interleukin-1. FASEB J 2 (1988) 108-113
5. Ohayon M.M., Caulet M., Phillip P., Guilleminault C., and Priest R.A.G. How sleep and mental disorders are related to complaints of daytime sleepiness. Arch Intern Med 157 (1997) 2645-2652
6. American Sleep Disorders Association Diagnostic Classification Steering Committee. International classification of sleep disorders. Diagnostic and coding manual. Rochester: American Sleep Disorders Association; 1990.
7. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Kales A., Tyson K., and Chrousos G.P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82 (1997) 1313-1316
8. Vgontzas A.N., Bixler E.O., Tan T.L., Kantner D., Martin L.F., and Kales A. Obesity without sleep apnea is associated with daytime sleepiness. Arch Intern Med 158 (1998) 1333-1337
9. Gami A.S., Caples S.M., and Somers V.K. Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am 32 4 (2003) 869-894
10. Fantuzzi G. Adipose tissue, adipokines and inflammation. J Allergy Clin Immunol 115 5 (2005) 911-919
11. Parish J.M., and Somers V.K. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc 79 8 (2004) 1036-1046
12. Krueger J.M., and Majide J.A. Humoral links between sleep and the immune system. Ann NY Acad Sci 992 (2003) 9-20
13. Lue F.A., Bail M., Jepthtah-Oshola J., Jepthtah-Ochola J., Carayanniotis K., Gorczynski R., and Moldofsky H. Sleep and cerebrospinal fluid interleukin-1 activity in the cat. Int J Neurosci 42 (1988) 179-183
14. Dickstein J.B., Moldofsky H., Lue F.A., and Hay J.B. Intracerecroventricular injection of TNF-a promotes sleep and is recovered in cervical lymph. Am J Physiol 276 (1999) R1018-R1022
15. Krueger J.M. Somnogenic activity of immune response modifiers. TIPS 11 (1990) 122-126
16. Obal F., and Krueger J.M. Biochemical regulation of non-rapid eye movement sleep. Front Biosci (2003) 520-550
17. Moldofsky H., Lue F.A., Eisen J., Keystone E., and Corczynski R.M. The relationship of interleukin-1 and immune functions to sleep in humans. Psychosom Med 48 (1986) 309-318
18. Covelli V., Massari F., Fallarca C., Fallacara C., Munno I., Jirillo E., Savastano E., et al. Interleukin-1 beta and beta endorphin circadian rhythms are inversely related in normal and stress-altered sleep. Int J Neurosci 63 (1992) 299-305
19. Irwin M., Thompson J., Miller C., Gillin J.C., and Ziegler M. Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans. J Clin Endocrinol Metabol 84 (1999) 1979-1985
20. Watkins L.R., Maier S.F., and Goehler L.E. Cytokine-to-brain communication: a review an analysis of alternative mechanisms. Life Sci 57 (1995) 1011-1026
21. Hansen M.K., Taishi P., Chen Z., and Krueger J.M. Vagotomy blocks the induction of interleukin-1 beta mRNA in the brain of rats in response to systemic IL-1 beta. J Neurosci 18 (1998) 2247-2253
22. Chen L., Duricka D., Nelson S., Mukherjee S., Bohnet S.G., Taishi P., et al. Influenza virus-induced sleep responses in mice with targeted disruptions in neuronal or inducible nitric oxide synthases. J Appl Physiol 97 (2004) 17-28
23. Dinarello C.A. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis. Kidney Int Suppl 38 (1992) S68-S77
24. Steiger A. Eating and sleeping-their relationship to ghrelin and leptin. Am J Physiol Regul Integr Comp Physiol 287 5 (2004) R1031-R1032
25. Obal F., Alt J., Taishi P., Gardi J., and Krueger J.M. Sleep in mice with non-functional growth-hormone-releasing hormone receptors. Am J Physiol Regul Integr Comp Physiol 284 (2003) R131-R139
26. Weikel J.C., Wichniak A., Ising M., Brunner H., Friess E., Held K., et al. Ghrelin promotes slow-wave sleep in humans. Am J Physiol Endocrinol Metab 284 (2003) E407-E415
27. Szentirmai E., Kapas L., and Krueger J.M. Ghrelin microinjection into forebrain sites induces wakefulness and feeding in rats. Am J Physiol Regul Integr Comp Physiol 292 (2007) R575-R585
28. Steiger A. Ghrelin and sleep-wake regulation. Am J Physiol Regul Integr Comp Physiol 292 (2007) R573-R574
29. Szentirmai E., and Krueger J.M. Obestatin alters sleep in rats. Neurosci Lett 404 (2006) 222-226
30. Sinton C.M., Fitch T.E., and Gershenfeld H.K. The effects of leptin on REM sleep and slow wave delta in rats are reversed by food deprivation. J Sleep Res 8 3 (1999) 197-203
31. Dzaja A., Dalal M.A., Himmerich H., Uhr M., Pollmacher T., and Schuld A. Sleep enhances nocturnal plasma ghrelin levels in healthy subjects. Am J Physiol Endocrinol Metab 286 (2004) E963-E967
32. Mullington J.M., Chan J.L., Van Dongen H.P., Szuba M.P., Samaras J., Price N.J., et al. Sleep loss reduces diurnal rhythm amplitude of leptin in healthy men. J Neuroendocrinol 15 (2003) 851-854
33. Taheri S., Lin L., Austin D., Young T., and Mignot E. Short sleep duration is associated with reduced sleep leptin, elevated ghrelin, and increased body mass index. PLoS Med 1 3 (2004) e62 [Epub 2004 Dec. 7]
34. Spiegel K., Knutson K., Leproult R., Tasali E., and Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and type II diabetes. J Appl Physiol 99 (2005) 2008-2019
35. Spiegel K., Tasali E., Pevev P., and Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 141 (2004) 846-850
36. Dinarello C.A., Cannon J.G., and Wolff S.M. New concepts on the pathogenesis of fever. Rev Infect Dis 10 (1988) 168-189
37. Dinarello C.A., and Krueger J.M. Induction of interleulin-1 by synthetic and naturally occurring muramyl peptides. Fed Proc 45 (1986) 2545-2548
38. Schuld A., Haack M., Hinze-Selch D., Mullington J., and Pollmacher T. Experimental studies on the interaction between sleep and immune system in humans. Psychother Psychosom Med Psychol 55 1 (2005) 29-35
39. Kelley K.W., Bluthe R.M., Dantzer R., Zhou J.H., Shen W.H., Johnson R.W., et al. Cytokine-induced sickness behaviour. Brain Behav Immun S1 (2003) S112-S118
40. Shoham S., Davenne D., Caby A.B., Dinarello C.A., and Krueger J.M. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am J Physiol 253 (1987) R142-R149
41. Dinarello C.A. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112 (1997) 321S-329S
42. Hirsch M., Carlander B., Verge M., Tafti M., Anaya J.M., Billiard M., and Sany J. Objective and subjective sleep disturbances in patients with RA: a reappraisal. Arthritis Rheum 37 (1994) 41-49
43. Darko D.F., Miller J.C., Gallen C., White J., Koziol J., Brown S.J., et al. Sleep electroencephalogram delta frequency amplitude, night plasma levels of TNF-alpha, and human immunodeficiency virus infection. Proc Natl Acad Sci USA 92 (1995) 12080-12084
44. Feldmann M., and Maini R.N. The role of cytokines in the pathogenesis of rheumatoid arthritis. Rheumatology(Oxford) 38 Suppl 2 (1999) 3-7
45. Zamarron C., Maceiras F., Mera A., and Gomez-Reino J.J. Effect of the first infliximab infusion on sleep and alertness in patients with active rheumatoid arthritis. Ann Rheum Dis 63 (2004) 88-90
46. Moldofsky H. Fibromyalgia, sleep disorder and chronic fatigue syndrome. Ciba Found Symp 173 (1993) 262-271
47. Vgontzas A. The diagnosis and treatment of chronic insomnia in adults. Sleep 28 9 (2005) 1047-1048
48. Moldofsky H., Lue F.A., Davidson J.R., and Corczynski R. Effects of sleep deprivation on human immune functions. FASEB J 3 (1989) 1972-1977
49. Opp M.R., and Krueger J.M. Anti-inteleukin-1b reduces sleep and sleep rebound after sleep deprivation in rats. Am J Physiol 266 (1994) R688-R695
50. Bauer J., Hohagen F., Ebert T., Timmer J., Ganter U., Krieger S., et al. Interleukin-6 serum levels in healthy persons correspond to the sleep-wake cycle. Clin Invest 72 (1994) 315
51. Redwine L., Hauger J., Gillin C., and Irwin M. Effects of sleep and sleep deprivation on Interleukin-6, growth hormone, cortisol and melatonin in humans. J Clin Endocrinol Metab 85 (2000) 3597-3603
52. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Lotsikas A., Zachman K., Kales A., et al. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 84 (1999) 2603-2607
53. Vgontzas A.N., Zoumakis E., Bixler E.O., Lin H.M., Follet H., Kales A., et al. Adverse effects of modest sleep restriction on sleepiness, performance and inflammatory cytokines. J Clin Endocrinol Metab 89 5 (2004) 2119-2126
54. Vgontzas A.N., Pejovic S., Zoumakis E., Lin H.M., Bixler E.O., Basta M., et al. Daytime napping after sleep loss decreases sleepiness, improves performance and causes beneficial changes in cortisol and interleukin-6 secretion. Am J Physiol Endocrinol Metab 292 (2007) E252-E261
55. Spath-Schwalbe E., Hansen K., Schmidt F., Schrezenmeier H., Marshall L., Burger K., et al. Acute effects of recombinant human interleukin-6 on endocrine and central nervous system functions in healthy men. J Clin Endocrinol Metab 83 (1998) 1573-1579
56. Morrow J.D., and Opp M.R. Sleep-wake behavior and responses of interleukin-6-deficient mice to sleep deprivation. Brain Behav Immun 19 (2005) 28-39
57. Benca R.M., Obermayer W.H., Thisted R.A., and Gillin J.C. Sleep and psychiatric disorders: a meta analysis. Arch Gen Psychiatry 49 (1992) 651-668
58. Irwin M. Effects of sleep and sleep loss on immunity and cytokines. Brain Behav Immun 16 (2002) 503-512
59. Alberti A., Sarchielli P., Gallinella E., Floridi A., Floridi A., Mazzotta G., et al. Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study. J Sleep Res 12 (2003) 305-311
60. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Hopper K., Lotsikas A., Lin H.M., Kales A., and Chrousos G.P. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance and hypercytokinemia. J Clin Endocrinol Metab 85 (2000) 1151-1158
61. Minogushi K., Tazaki T., Yokoe T., Minogushi H., Watanabe Y., Yamamoto M., et al. Elevated production of Tumor Necrosis Factor-A by monocytes in patients with obstructive sleep apnea syndrome. Chest 126 (2004) 1473-1479
62. Mills P.J., and Dimsdale J.E. Sleep apnea: a model for studying cytokines, sleep and sleep disruption. Brain Behav Immun 18 (2004) 298-303
63. Vassilakopoulos T., Katsaounou P., Karatza M.H., Kollintza A., Zakynthinos S., and Roussos C. Strenuous resistive breathing induces plasma cytokines: role of antioxidants and monocytes. Am J Respir Crit Care Med 166 (2002) 1572-1578
64. Fried S.K., Bunklin D.A., and Greenberg A.S. Omental and subcutaneous adipose tissue of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83 (1998) 847-850
65. Ciftci T.U., Kozturk O., Bukan N., and Bilgihan A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 28 (2004) 87-91
66. Vgontzas A.N., Bixler E.O., and Chrousos G.P. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med 254 (2003) 32-44
67. Bixler E.O., Vgontzas A.N., Lin H.M., Calhoun S.L., Vela-Bueno A., and Kales A. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes and depression. J Clin Endocrinol Metab 90 (2005) 4510-4515
68. Resta O., Foschino-Barbaro M.P., Legari G., Talamo S., Bonfitto P., Palumbo A., et al. Sleep-related breathing disorders, loud snoring, and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord 25 (2001) 669-675
69. Vgontzas A., Legro R., Bixler E., Grayev A., Kales A., and Chrousos G.P. Polycystic ovary syndrome is associated with obsytructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 86 (2001) 517-520
70. Fogel R., Malhotra A., Pillar G., Pittman S.D., Dunaif A., and White D.P. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 86 (2001) 1175-1178
71. Gopal M., Duntley S., Uhles M., and Attarian H. The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome. Sleep Med 3 (2002) 401-404
72. Vgontzas A., and Chroussos G. Sleep-disordered breathing, sleepiness, and insulin resistance: is the latter a consequence, a pathogenetic factor or both?. Sleep Med 3 (2001) 389-391
73. Tasali E., Van Cauter E., and Ehrmann D.A. Relationship between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. J Clin Endocrinol Metab 91 1 (2006) 36-42
74. Vgontzas A., Trakada G., Bixler E., Lin H.M., Pejovic S., Zoumakis E., et al. Plasma IL-6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea. Metabolism 55 (2006) 1076-1082
75. Libby P., and Ridker P.M. Novel inflammatory markers of coronary risk: theory versus practice. Circulation 100 (1999) 1148-1150
76. Glass C.K., and Witztum J.L. Atherosclerosis: the road ahead. Cell 104 (2001) 503-516
77. Herskowitz A., Choi S., Ansari A.A., and Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 146 (1995) 419-428
78. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Lepage S., and Braunwald E. Elevation of tumor necrosis factor-A and increased risk of recurrent coronary events after myocardial infarction. Circulation 101 (2000) 2149-2153
79. Yudkin J.S., Kumari M., Humphries S.E., and Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 148 (2000) 209-214
80. Lindmark E., Diderholm E., Wallentin L., and Siegbahn A. Relationship between interleukin-6 and mortality in patients with unstable coronary artery disease: the effects of an early invasive or noninvasive strategy. JAMA (2001) 2107-2113
81. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentrations of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
82. DeFronzo R.A., and Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14 3 (1991) 173-194
83. Semenkovich C.F. Insulin resistance and atherosclerosis. J Clin Invest 116 (2006) 1813-1822
84. Fernandez-Real J.M., Vayreda M., Richart C., Gutierrez C., Broch M., Vendrell J., and Ricart W. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 86 (2001) 1154-1159
85. Fernandez-Real J.M., Broch M., Ricart W., Casamitjana R., Gutierrez C., Vendrell J., and Richart C. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 47 (1998) 1757-1762
86. Andreozzi F., Laratta E., Cardellini M., Marini M.A., Lauro R., Hribal M.L., et al. Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects. Diabetes 55 (2006) 2021-2024
87. Schulz R., Hummel C., Heinemann S., Seeger W., and Grimmnger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 165 (2002) 67-70
88. Imigawa S., Yamaguchi Y., Higushi M., Neichi T., Hasegawa Y., Mukai H.Y., et al. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome. Blood 98 (2001) 1255-1257
89. Gozal D., Lipton A.J., and Jones K.L. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea syndrome. Sleep 25 (2002) 59-65
90. Lavie L., Kraiczi H., Hefetz A., Ghandour H., Perelman A., Hedner J., and Lavie P. Plasma VEGF in sleep apnea syndrome: effects of nCPAP treatment. Am J Respir Crit Care Med 165 (2002) 1624-1628
91. Cherniack N. Inflammatory ideas about Sleep apnea. Respiration 71 (2004) 20-21
92. Imagawa S., Yamagutsi Y., Ogawa K., Obara N., Suzuki N., Yamamoto M., et al. Interleukin-6 and Tumor Necrosis Factor-A in patients with obstructive sleep apnea-hypopnea syndrome. Respiration 71 (2004) 24-29
93. Vgontzas A.N., Zoumakis M., Papanicolaou D.A., Bixler E.O., Prolo P Vela-Bueno A., Kales A., et al. Chronic insomnia is associated with a shift of interleukin-6 and tumour necrosis factor secretion from nighttime to daytime. Metabolism 51 7 (2002) 887-892
94. Ip M.M.S., Lam B., Ng M.M.T., Lam W.K., Tsang K.W., and Lam K.S. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165 (2002) 670-676
95. Punjabi N.M., Sorkin J.D., Katzel L., Goldberg A.P., Schwartz A.P., and Smith P.L. Sleep-disordered breathing and insulin resistance in middle aged and overweight men. Am J Respir Crit Care Med 165 (2002) 677-682
96. Tasali E., and Van Gauter M. Sleep disordered breathing and the current epidemic of obesity. Am J Respir Crit Care Med 165 (2002) 562-563
97. Vgontzas A.N., Bixler E.O., and Chrousos G.P. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9 (2005) 211-224
98. Ip M.S.M., Lam K.S.L., Ho C., Tsang K.W., and Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118 (2000) 580-586
99. Chin K., Shimizu K., Nakamura T., Narai N., Masuzaki H., Ogawa Y., et al. Changes in intraabdominal visceral fat and leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100 (1999) 706-712
100. Hatipoglu U., and Rubistein I. Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 70 (2003) 665-671
101. Finck B.N., and Johnson R.W. Tumor necrosis factor alpha regulates secretion of the adipocyte-derived cytokine, leptin. Microsc Res Tech 50 (2000) 209-215
102. Zhang X.L., Yin K.S., Mao H., Wang H., and Yang Y. Serum adiponectin level in patients with obstructive sleep apnea-hypopnea syndrome. Chin Med J (Engl) 117 1 (2004) 1603-1606
103. Zhang X.L., Yin K.S., Wang H., and Su S. Serum adiponectin levels in adult male patients with obstructive sleep apnea-hypopnea syndrome. Respiration 73 1 (2006) 73-77
104. Makino S., Handa H., Suzukawa K., Fujiwara M., Nakamura M., Muraoka S., et al. Obstructive sleep apnoea, plasma adiponectin levels and insulin resistance. Clin Endocrinol 64 (2006) 12-19
105. Wolk R., Svatikova A., Nelson C.A., Gami A.S., Govender K., Winnicki M., et al. Plasma levels of adiponectin, a novel adipocyte-derived hormone in sleep apnea. Obes Res 13 1 (2005) 186-190
106. Harsch I.A., Koebnick C., Wallaschofski H., Schahin S.P., Hahn E.G., Ficker J.H., et al. Resistin levels in patients with obstructive sleep apnea syndrome - the link to subclinical inflammation?. Med Sci Monit 10 9 (2004) CR510-CR515
107. Kralisch S., Klein J., Lossner U., Bluher M., Paschke R., Stumvoll M., and Fasshauer M. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 289 4 (2005) E586-E590
108. Yokoe T., Minogushi K., Matsuo H., Oda N., Minogushi H., Yoshino G., et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107 (2003) 1129-1134
109. Arter J.L., Chi D.S., Girish M., Fitzerald S.M., Guha B., and Krishnaswamy G. Obstructive sleep apnea, inflammation and cardiopulmonary disease. Front Biosci 9 (2004) 2892-2900
110. Entzian P., Linnemann K., Schlaak M., and Zabel P. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med 153 (1996) 1080-1086
111. Reid M.B., Lannergen J., and Westerblad H. Respiratory and limb muscle weakness induced by tumour necrosis factor alpha. Am J Respir Crit Care Med 166 (2002) 479-484
112. Harsch I.A., Wallaschofski H., Koebnick C., Schahin S.P., Hahn E.G., Ficker J.H., et al. Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance. Respiration 71 (2004) 580-586
113. Kataoka T., Enomoto F., Kim R., Yokoi H., Fujimori M., Ando I., et al. The effect of surgical treatment of obstructive sleep apnea syndrome on the plasma TNF-a levels. Tohoku J Exp Med 204 (2004) 267-272
114. Sabato R., Guido P., Salerno F.G., Goldberg A.P., Schwartz A.P., and Smith P.L. Airway inflammation in patients affected by obstructive sleep apnea. Monaldi Arch Chest Dis 65 (2006) 102-105
115. Vgontzas A.N., Zoumakis E., Lin H.M., Bixler E.O., Trakada G., and Chroussos P. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumour necrosis factor-alpha antagonist. J Clin Endocrinol Metab 89 9 (2004) 4409-4413
116. Vgontzas A.N., Zoumakis M., Bixler E.O., Lin H.M., Prolo P., Vela-Bueno A., et al. Impaired nighttime sleep in healthy old versus young adults is associated with elevated plasma interleukin-6 and cortisol levels: physiologic and therapeutic implications. J Clin Endocrinol Metab 88 (2003) 2087-2095
117. Brower K.J., Aldrich M.S., and Hall J.M. Polysomnographic and subjective sleep predictors of alcoholic relapse. Alcohol Clin Exp Res 22 (1998) 1864-1871
118. Drummond S.P., Gillin J.C., Smith T.L., and DeModena A. The sleep of abstinent pure primary alcoholic patients: natural history and relationship to relapse. Alcohol Clin Exp Res 22 (1998) 1796-1802
119. Irwin M., Rinetti G., Redwine L., Motivala S., Dang J., and Ehlers C. Nocturnal proinflammatory cytokine-associated sleep disturbances in abstinent African American alcoholics. Brain Behav Immun 18 4 (2004) 349-360
120. Anisman H., and Merali Z. Cytokines, stress and depressive illness. Brain Behav Immun 16 (2002) 513-524
121. Anisman H., and Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann Med 35 (2003) 2-11
122. Sakurai T. Role of orexins and orexin receptors in central regulation of feeding behaviour and energy homeostasis. CNS Neurol Disord Drug Targets 5 (2006) 313-325
123. Himmerich H., Beitinger P.A., Fulda S., Griegling I., Epplen J.T., and Dahmen N. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy. Arch Intern Med 166 (2006) 1739-1743
124. Okun M.L., Giese S., Einen M., Mignot E., and Coussons-Read M.E. Exploring the cytokine and endocrine involvement in narcolepsy. Brain Behav Immun 18 4 (2004) 326-332
125. Wieczorec S., Gencik M., Rujescu D., Tonn P., Wehrle R., Linseisen J., and Wolfram G. TNFA promoter polymorphisms and narcolepsy. Tissue Antigens 61 6 (2003) 437-442
126. Wieczorec S., Dahmen N., Kasten M., Epplen J.T., and Gencik M. A rare form of narcolepsy (HLA-DR2-) shows possible association with (functionally relevant) alpha-interferon gene polymorphisms. Psychiatr Genet 14 (2004) 47-51